Logo image
Economic impacts of alternative kidney transplant immunosuppression: A national cohort study
Journal article   Open access   Peer reviewed

Economic impacts of alternative kidney transplant immunosuppression: A national cohort study

David A. Axelrod, Yasar Caliskan, Mark A. Schnitzler, Huiling Xiao, Vikas R. Dharnidharka, Dorry L. Segev, Mara McAdams-DeMarco, Daniel C. Brennan, Henry Randall, Tarek Alhamad, …
Clinical transplantation, v 34(4), e13813
Apr 2020
PMID: 32027049
url
https://doi.org/10.1111/ctr.13813View
Published, Version of Record (VoR) Open Maybe Open Access (Publisher Bronze)

Abstract

health expenditures induction immunosuppression kidney transplantation maintenance immunosuppression Economics Registries
Understanding the economic implications of induction and maintenance immunosuppression (ISx) is important in developing personalized kidney transplant (KTx) care. Using data from a novel integrated data set including financial records from the University Health System Consortium, Medicare, and pharmacy claims (2007‐2014), we estimated the differences in the impact of induction and maintenance ISx regimens on transplant hospitalization costs and Medicare payments from KTx to 3 years. Use of thymoglobulin (TMG) significantly increased transplant hospitalization costs ( $12 006; P = .02), compared with alemtuzumab and basiliximab. TMG resulted in lower Medicare payments in posttransplant years 1 (−$ 2058; P = .05) and 2 (− $1784; P = .048). Patients on steroid‐sparing ISx incurred relatively lower total Medicare spending (−$ 10 880; P = .01) compared with patients on triple therapy (tacrolimus, antimetabolite, and steroids). MPA/AZA‐sparing, mammalian target of rapamycin inhibitors‐based, and cyclosporine‐based maintenance ISx regimens were associated with significantly higher payments. Alternative ISx regimens were associated with different KTx hospitalization costs and longer‐term payments. Future studies of clinical efficacy should also consider cost impacts to define the economic effectiveness of alternative ISx regimens.

Metrics

10 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Surgery
Transplantation
Logo image